Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK GBp

Worldwide Healthcare Trust PLC (WWHL.XC)

Compare
332.00
+1.00
+(0.30%)
At close: February 21 at 4:11:03 PM GMT
Loading Chart for WWHL.XC
DELL
  • Previous Close 331.00
  • Open 331.00
  • Bid --
  • Ask 336.00 x --
  • Day's Range 331.00 - 333.50
  • 52 Week Range 2.87 - 333.50
  • Volume 12,095
  • Avg. Volume 26,966
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Nov 25, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 13, 2024
  • 1y Target Est --

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.

www.worldwidewh.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: WWHL.XC

View More

Compare To: WWHL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WWHL.XC

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    1.67B

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    85.53%

  • Return on Assets (ttm)

    6.12%

  • Return on Equity (ttm)

    9.51%

  • Revenue (ttm)

    235.19M

  • Net Income Avi to Common (ttm)

    201.16M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    73.8M

  • Total Debt/Equity (mrq)

    3.31%

  • Levered Free Cash Flow (ttm)

    125.66M

Research Analysis: WWHL.XC

View More

Company Insights: WWHL.XC

Research Reports: WWHL.XC

View More